FDA Approves Boston Scientific’s Stents Platform

The FDA granted approval for Boston Scientific’s Innova Vascular Self-Expanding Stent system to treat patients with narrowing or blockages in the superficial femoral artery or proximal popliteal artery.

These conditions will cause circulatory disorder called peripheral artery disease, which may result in limb amputation, according to Boston Scientific peripheral interventions President Jeff Mirviss.

The system features a Nitinol self-expanding bare metal stent with an advanced delivery system, and is available in different sizes ranging 5mm to 8mm in diameter and 20mm to 200mm in length.

The platform is said to serve as the foundation for the new Eluvia Drug-Eluting Vascular Stent, which is specifically designed for the superficial femoral artery. — Michael Cipriano